| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $142M | — | — | — | — |
| Op. Income | $49M | — | — | — | — |
| Gross Margin | 48.1% | — | — | — | — |
| Net Margin | 29.4% | — | — | — | — |
| EPS (Diluted) | $0.81 | — | — | — | — |
| Free Cash Flow | $53M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $142M |
| Cost of Revenue | $74M |
| GROSS PROFIT | $68M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $17M |
| SG&A Expenses | $17M |
| Other Expenses | $3M |
| Operating Expenses | $19M |
| Cost & Expenses | $93M |
| OPERATING INCOME | $49M |
| Interest Income | $5M |
| Interest Expense | $0 |
| Other Income/Expenses | $7M |
| INCOME BEFORE TAX | $56M |
| Income Tax Expense | $14M |
| Net Income from Continuing Ops | $42M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $42M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $42M |
| D&A | $3M |
| EBIT | $49M |
| EBITDA | $52M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $142M |
| Cost of Revenue | $74M |
| GROSS PROFIT | $68M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $17M |
| SG&A Expenses | $17M |
| Other Expenses | $3M |
| Operating Expenses | $19M |
| Cost & Expenses | $93M |
| OPERATING INCOME | $49M |
| Interest Income | $5M |
| Interest Expense | $0 |
| Other Income/Expenses | $7M |
| INCOME BEFORE TAX | $56M |
| Income Tax Expense | $14M |
| Net Income from Continuing Ops | $42M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $42M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $42M |
| D&A | $3M |
| EBIT | $49M |
| EBITDA | $52M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $42M |
| Depreciation & Amortization | $3M |
| Stock-Based Compensation | $12M |
| Deferred Income Tax | -$1M |
| Other Non-Cash Items | -$642.0K |
| Change in Working Capital | $245.0K |
| OPERATING CASH FLOW | $55M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$144M |
| Sales/Maturities of Investments | $111M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$35M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$258.0K |
| Common Dividends Paid | -$32M |
| Other Financing Activities | $15M |
| NET CASH FROM FINANCING | -$17M |
| FREE CASH FLOW | $53M |
| Net Change in Cash | $3M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $98M |
| Short-Term Investments | $198M |
| Net Receivables | $71M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $367M |
| PP&E (Net) | $166M |
| Goodwill | $0 |
| Intangible Assets | $20M |
| Long-Term Investments | $218M |
| Tax Assets | $0 |
| Other Non-Current Assets | $31M |
| TOTAL NON-CURRENT ASSETS | $435M |
| TOTAL ASSETS | $802M |
| Account Payables | $9M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$6M |
| TOTAL CURRENT LIABILITIES | $73M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $9M |
| TOTAL NON-CURRENT LIABILITIES | $150M |
| TOTAL LIABILITIES | $222M |
| Common Stock | $582.0K |
| Additional Paid-In Capital | $982M |
| Retained Earnings | -$108M |
| Treasury Stock | -$320M |
| Accum. Other Comp. Income | -$4M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $550M |
| Minority Interest | $29M |
| TOTAL EQUITY | $579M |
| TOTAL LIABILITIES & EQUITY | $802M |
| Total Debt | $140M |
| Net Debt | $42M |
